Advertisement

Sports Medicine

, Volume 4, Issue 3, pp 157–163 | Cite as

Effect of Acetazolamide on Exercise at Altitude

  • A. R. Bradwell
  • P. W. Dykes
  • J. H. Coote
Article

Keywords

Carbonic Anhydrase Exercise Performance Acetazolamide Acute Mountain Sickness Muscle Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Birmingham Medical Research Expeditionary Society. Acetazolamide in the control of acute mountain sickness. Lancet 1: 180–183, 1981Google Scholar
  2. Boutellier U, Howald H, di Prampero PE, Giezendanner D, Cerretelli P. Human muscle adaptations to chronic hypoxia. In Hypoxia, exercise and altitude, Proceedings of the Third Banff International Hypoxia Symposium, pp. 273–281. Alan R. Liss Inc., New York, 1983Google Scholar
  3. Bradwell AR, Delamere JP. The effect of acetazolamide on the proteinuria of altitude. Aviation, Space and Environmental Medicine 53 (1): 40–43, 1982Google Scholar
  4. Bradwell AR, Delamere JP, Mackintosh JH. Acetazolamide in the mountains. Lancet 1: 730, 1981PubMedCrossRefGoogle Scholar
  5. Bradwell AR, Dykes PW, Coote JH, Forster PJE, Milles JJ, et al. Effect of acetazolamide on exercise performance and muscle mass as high altitude. Lancet 1: 1001–1005, 1986PubMedCrossRefGoogle Scholar
  6. Carter N, Jeffrey S. Carbonic anhydrase: update and new horizons. Biochemical Society Transactions 13: 531–533, 1985PubMedGoogle Scholar
  7. Hackett PH, Rennie D, Levine HD. The incidence, importance and prophylaxis of acute mountain sickness. Lancet 2: 1149–1154, 1976PubMedCrossRefGoogle Scholar
  8. Hackett PH, Schoene RB, Winslow RM, Peters RM, West J. Acetazolamide and exercise in sojourners to 6,300m — a preliminary study. Medicine and Science in Sports and Exercise 17: 593–597, 1985PubMedCrossRefGoogle Scholar
  9. Hultgren HN. High altitude medical problems. In Sutton et al. (Eds) Hypoxia: man at altitude, pp. 161–167, Thieme-Stratton Inc., New York, 1982Google Scholar
  10. Lassen NA, Friberg L. Effects of acetazolamide on cerebral blood flow and brain tissue oxygenation. Postgraduate Medical Journal, in press, 1986Google Scholar
  11. Minors DS. Abnormal pressure. In Case RM (Ed.) Variations in human physiology, pp. 78–110, Manchester University Press, Manchester, 1985Google Scholar
  12. Schoene RB, Bates PW, Larson EB, Pierson DJ. Effect of acetazolamide on normoxic and hypoxic exercise in humans at sea level. Journal of Applied Physiology 55: 1772–1776, 1983PubMedGoogle Scholar
  13. Sperryn PN. Muscle and training adaptations. In Sport and Medicine, pp. 52–53, Butterworths, London, 1983Google Scholar
  14. Sutton JR, Coates G. Pathophysiology of high-altitude illness. Exercise and Sport Sciences Reviews 11: 210–231, 1983PubMedCrossRefGoogle Scholar
  15. Sutton JR, Houston CS, Mansell AL, McFadden M, Hackett P, et al. Effect of acetazolamide on hypoxaemia during sleep at high altitude. New England Journal of Medicine 301: 1329–1331, 1979PubMedCrossRefGoogle Scholar
  16. Swenson ER, Maren TH. A quantitative analysis of C02 transport at rest and during maximal exercise. Respiration Physiology 35: 129–159, 1978PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1987

Authors and Affiliations

  • A. R. Bradwell
    • 1
  • P. W. Dykes
    • 1
  • J. H. Coote
    • 1
  1. 1.University Departments of Immunology, Medicine and Physiology, The Medical SchoolBirmingham UniversityBirminghamEngland

Personalised recommendations